Perrigo Sets Date Of Shareholder Meeting To Approve Elan Acquisition

ALLEGAN (WWJ) -- Perrigo Co. (NYSE: PRGO) announced that it has scheduled a shareholder meeting for Monday, Nov. 18 in connection with Perrigo's proposed previously announced acquisition of Elan Corp. (NYSE: ELN).

Perrigo's special meeting of shareholders will be held at 10 a.m. Nov. 18 at Perrigo headquarters at 490 Eastern Ave. in Allegan. The meeting is being held to seek shareholder adoption of the transaction agreement and approval of the merger and related matters.

Holders of Perrigo common stock of record as of 5 p.m. Eastern time Oct. 15 will be entitled to attend and vote at the meeting.

The company expects to begin mailing a joint proxy statement and prospectus to its shareholders in the coming days. The joint proxy statement and prospectus will provide information for shareholders, as well as instructions for shareholders on how to vote their shares.

From its beginnings as a packager of generic home remedies in 1887, Allegan-based Perrigo has become the world's largest manufacturer of over-the-counter pharmaceutical products for the store brand market. Perrigo makes OTC and generic prescription drugs, infant formulas, nutritional products, animal health, dietary supplements and active pharmaceutical ingredients. The company operates in the United States, Israel, Mexico, the United Kingdom, India, China and Australia.

More at www.perrigo.com.